Azathioprine, cyclophosphamide and chlorambucil

Area of Science:

• Rheumatology
• Immunology
• Pharmacology

Background:

• Immunosuppressive agents are vital for managing severe conditions like systemic necrotizing vasculitides.
• Their use is expanding to chronic inflammatory disorders, including rheumatoid arthritis.
• These drugs reduce cell division but vary in mechanism, speed, and application.

Purpose of the Study:

• To review the clinical applications of key immunosuppressive agents in rheumatic diseases.
• To highlight the evidence supporting their efficacy.
• To discuss their mechanisms of action and major side effects.

Main Methods:

• Review of clinical applications of azathioprine, cyclophosphamide, and chlorambucil.
• Examination of laboratory evidence for drug effects.
• Discussion of drug mechanisms and side effects.

Main Results:

• Azathioprine is an alternative for older rheumatoid arthritis patients.
• Cyclophosphamide has significantly improved outcomes in vasculitis.
• Chlorambucil benefits children with amyloidosis secondary to juvenile chronic arthritis.

Conclusions:

• Immunosuppressive agents have diverse roles and mechanisms in treating rheumatic diseases.
• Understanding their specific applications and side effects is crucial for patient management.
• These drugs offer significant therapeutic benefits across a spectrum of rheumatic conditions.